Diaz Brinton's guest appearances

Diaz Brinton

BrainStorm by UsAgainstAlzheimer's

Neurology Grand Rounds

Straight from a Scientist Medical Research Education and Discussion Podcast

Frank LaFerla

Wendy Suzuki

Bruce Miller

Scott Turner

David Morgan

Lisa Genova

Lisa Mosconi

Alex Israel

Mary Newport

Ellen Goodman

Jill Smith

Stephanie Martin

Mark Shriver

Rachel Paul

Jonathan Jackson

OwlTail

Women are almost twice as likely to develop Alzheimer's disease as men. However, this is NOT because they live longer. When we look into the aging brain, males and females experience different timelines. The molecular underpinnings of these sex differences could make a huge impact on our understanding of Alzheimer's disease. Dr. Roberta Diaz Brinton is spearheading research into sex differences in Alzheimer's disease. She works to discover how to protect the aging female brain from these increased risk factors.   This episode features another throwback recorded in San Diego, CA, where Connor Wander attended the  BrightFocus Alzheimer's Disease Fast Track conference, followed by the Society for Neuroscience annual meeting.   About Dr. Brinton  Dr. Roberta Diaz Brinton leads the Center for Innovation in Brain Science at the University of Arizona that studies diseases of aging, Alzheimer’s, Multiple Sclerosis, Parkinson’s and ALS. Dr. Brinton is an internationally recognized expert in the systems biology of Alzheimer’s disease. She is developing the first regenerative therapeutic to regenerate the degenerated brain. Her analysis focuses on the brain at greatest risk for Alzheimer’s: the aging female brain. Her findings show that the sex difference in Alzheimer’s disease is not because women live longer than men, as commonly thought, but rather because the disease starts earlier in the female brain. Her insights into these key transition states of the aging brain provide therapeutic opportunities to prevent, delay, and treat neurodegenerative disease.   More Information  Read more about Dr. Roberta Diaz Brinton's research and scholarship.   Learn more on the Brinton Lab Website.      The Society for Neuroscience (SfN) is a well-known conference, drawing 28 thousand people annually. In contrast, AD Fast Track is a much smaller conference put on by BrightFocus, a foundation built to support AD and glaucoma research and awareness. Many of the speakers at the event were directly supported by BrightFocus (Lamb, Brinton, Head, Grinberg).   Alzheimer's disease research is reinventing itself in the wake of past failures. New understandings of disease complexity, paired with recent advances in technology and a renewed surge in funding for research fuels new hope for a cure or treatment. Yet we aren't putting all our eggs in one basket. This series explores Alzheimer's disease research and the variety of research strategies with the common goal of curing Alzheimer's disease.     Any other questions?  Let us know!  We appreciate your feedback.   You can now support the podcast at https://www.patreon.com/sfspodcast.  Many thanks to our past and present supporters!    Thanks to Plant Warrior for their support.  Use discount code SFS10 at checkout for 10% off your purchase of plant-based protein.

Women are almost twice as likely to develop Alzheimer's disease as men. However, this is NOT because they live longer. When we look into the aging brain, males and females experience different timelines. The molecular underpinnings of these sex differences could make a huge impact on our understanding of Alzheimer's disease. Dr. Roberta Diaz Brinton is spearheading research into sex differences in Alzheimer's disease. She works to discover how to protect the aging female brain from these increased risk factors. This episode features another throwback recorded in San Diego, CA, where Connor Wander attended the <a href="https://www.brightfocus.org/alzheimers-disease/news/alzheimers-fast-track-shaping-new-generation-alzheimers-researchers" rel="nofollow" target="_blank"> BrightFocus Alzheimer's Disease Fast Track conference</a>, followed by the Society for Neuroscience annual meeting. About Dr. Brinton Dr. Roberta Diaz Brinton leads the Center for Innovation in Brain Science at the University of Arizona that studies diseases of aging, Alzheimer’s, Multiple Sclerosis, Parkinson’s and ALS. Dr. Brinton is an internationally recognized expert in the systems biology of Alzheimer’s disease. She is developing the first <a href="https://www.youtube.com/watch?v=kFJOLXoAR34" rel="noopener nofollow" target="_blank">regenerative therapeutic</a> to regenerate the degenerated brain. Her analysis focuses on the brain at greatest risk for Alzheimer’s: the aging female brain. Her findings show that the sex difference in Alzheimer’s disease is not because women live longer than men, as commonly thought, but rather because the disease starts earlier in the female brain. Her insights into these key transition states of the aging brain provide therapeutic opportunities to prevent, delay, and treat neurodegenerative disease. More Information Read more about Dr. Roberta Diaz Brinton's <a href="http://www.robertabrinton.com/biography" rel="noopener nofollow" target="_blank">research and scholarship</a>. Learn more on the <a href="http://www.robertabrinton.com/" rel="noopener nofollow" target="_blank">Brinton Lab Website</a>. The <a href="https://www.sfn.org/" rel="noreferrer noopener nofollow" target="_blank">Society for Neuroscience</a> (SfN) is a well-known conference, drawing 28 thousand people annually. In contrast, AD Fast Track is a much smaller conference put on by BrightFocus, a foundation built to support AD and <a href="https://www.aao.org/eye-health/diseases/what-is-glaucoma" rel="noreferrer noopener nofollow" target="_blank">glaucoma</a> research and awareness. Many of the speakers at the event were directly supported by BrightFocus (Lamb, Brinton, Head, Grinberg). Alzheimer's disease research is reinventing itself in the wake of past failures. New understandings of disease complexity, paired with recent advances in technology and a renewed surge in funding for research fuels new hope for a cure or treatment. Yet we aren't putting all our eggs in one basket. This series explores Alzheimer's disease research and the variety of research strategies with the common goal of curing Alzheimer's disease. Any other questions?  <a href="https://www.straightfromascientist.com/contact-us/" rel="noreferrer noopener nofollow" target="_blank">Let us know!</a>  We appreciate your feedback. You can now support the podcast at <a href="https://www.patreon.com/sfspodcast" rel="noreferrer noopener nofollow" target="_blank">https://www.patreon.com/sfspodcast</a>.  Many thanks to our past and present supporters!  Thanks to <a href="https://www.plantwarrior.co/" rel="noreferrer noopener nofollow" target="_blank">Plant Warrior</a> for their support.  Use discount code SFS10 at checkout for 10% off your purchase of plant-based protein.

Ep. 44: Sex Differences in Alzheimer's Disease with Dr. Roberta Diaz Brinton and Connor Wander

Howard Fillit

Our guest is Dr. Roberta Diaz Brinton, R. Pete Vanderveen Chair in Therapeutic Discovery and Development and Professor of Pharmacology and Pharmaceutical Sciences, Biomedical Engineering and Neurology at the University of Southern California, who has led groundbreaking research investigating the hormones and neurosteroids that defend and repair the brain’s cells as well as understanding why women are at higher risk for Alzheimer's. She was joined on the call by Dr. Howard Fillit, Founding Executive Director and Chief Science Officer of the Alzheimer’s Drug Discovery Foundation, which has funded some of Dr. Brinton’s research.Support the show (https://www.usagainstalzheimers.org)

Our guest is Dr. Roberta Diaz Brinton, R. Pete Vanderveen Chair in Therapeutic Discovery and Development and Professor of Pharmacology and Pharmaceutical Sciences, Biomedical Engineering and Neurology at the University of Southern California, who has led groundbreaking research investigating the hormones and neurosteroids that defend and repair the brain’s cells as well as understanding why women are at higher risk for Alzheimer's. She was joined on the call by Dr. Howard Fillit, Founding Executive Director and Chief Science Officer of the Alzheimer’s Drug Discovery Foundation, which has funded some of Dr. Brinton’s research.<a href="https://www.usagainstalzheimers.org" rel="payment nofollow" target="_blank">Support the show</a> (<a href="https://www.usagainstalzheimers.org" rel="nofollow" target="_blank">https://www.usagainstalzheimers.org</a>)

[AlzTalks-Archive] Defending and Repairing Brain Cells - Dr. Roberta Diaz Brinton & Dr. Howard Fillit